Moderna
Moderna debt and dilution—
Borrowings, liquidity, share count and stock-based dilution.
Total debt
USD millions
Reported borrowing balances are unavailable in the extracted statements for this period.
Cash & equivalents
USD millions
Net debt
USD millions
Reported borrowing balances are unavailable in the extracted statements for this period.
Debt / equity
×
Reported borrowing balances are unavailable in the extracted statements for this period.
Debt / assets
%
Reported borrowing balances are unavailable in the extracted statements for this period.
Net debt / EBITDA
× · TTM
Trailing EBITDA is zero or negative, so this ratio is undefined.
Debt / FCF
× · TTM
Trailing free cash flow is zero or negative, so this ratio is undefined.
Interest coverage
× · TTM
The reported inputs required for this metric are unavailable in the extracted statements for this period.
Current ratio
×
Diluted shares
Million shares
Basic shares
Million shares
Share count growth
%
Share repurchases
USD millions
Quarterly data
| Fiscal period | Ended | Total debtUSD millions | Cash & equivalentsUSD millions | Net debtUSD millions | Debt / equity× | Debt / assets% | Net debt / EBITDA× | Debt / FCF× | Interest coverage× | Current ratio× | Diluted sharesMillion shares | Basic sharesMillion shares | Share count growth% | Share repurchasesUSD millions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 Q2 | Jun 30, 2026 | — | 1,723 | — | — | — | — | — | — | 2.29× | 398 | 398 | 2.58% | — |
| FY 2026 Q1 | Mar 31, 2026 | — | 1,908 | — | — | — | — | — | — | 2.41× | 395 | 395 | 2.33% | — |
| FY 2025 Q4 | Dec 31, 2025 | — | 2,595 | — | — | — | — | — | — | 3.29× | 391.97 | 391.97 | 1.29% | — |
| FY 2025 Q3 | Sep 30, 2025 | — | 1,132 | — | — | — | — | — | — | 3.93× | 390 | 390 | 1.3% | — |
| FY 2025 Q2 | Jun 30, 2025 | — | 1,279 | — | — | — | — | — | — | 3.93× | 388 | 388 | 1.04% | — |
| FY 2025 Q1 | Mar 31, 2025 | — | 1,623 | — | — | — | — | — | — | 4.22× | 386 | 386 | 1.05% | — |
| FY 2024 Q4 | Dec 31, 2024 | — | 1,927 | — | — | — | — | — | — | 3.67× | 386.98 | 386.98 | 1.3% | 0 |
| FY 2024 Q3 | Sep 30, 2024 | — | 1,644 | — | — | — | — | — | — | 4.39× | 399 | 385 | 1.05% | 0 |
| FY 2024 Q2 | Jun 30, 2024 | — | 2,478 | — | — | — | — | — | — | 4.09× | 384 | 384 | 0.79% | 0 |
| FY 2024 Q1 | Mar 31, 2024 | — | 2,051 | — | — | — | — | — | — | 4.03× | 382 | 382 | -1.04% | 0 |
| FY 2023 Q4 | Dec 31, 2023 | — | 2,907 | — | — | — | — | — | — | 3.42× | 382 | 382 | -1.56% | 0 |
| FY 2023 Q3 | Sep 30, 2023 | — | 2,932 | — | — | — | — | — | — | 2.46× | 381 | 381 | -2.31% | 1 |
| FY 2023 Q2 | Jun 30, 2023 | — | 3,801 | — | — | — | — | — | — | 3.39× | 381 | 381 | -3.79% | 628 |
| FY 2023 Q1 | Mar 31, 2023 | — | 3,441 | — | — | — | — | — | — | 3.46× | 405 | 386 | -3.98% | 526 |
| FY 2022 Q4 | Dec 31, 2022 | — | 3,205 | — | — | — | — | — | — | 2.73× | 407.1 | 388.07 | -4.41% | 402 |
| FY 2022 Q3 | Sep 30, 2022 | — | 3,027 | — | — | — | — | — | — | 2.1× | 412 | 390 | -3.47% | 1,006 |
| FY 2022 Q2 | Jun 30, 2022 | — | 2,873 | — | — | — | — | — | — | 1.99× | 419 | 396 | -1.49% | 1,298 |
| FY 2022 Q1 | Mar 31, 2022 | — | 5,048 | — | — | — | — | — | — | 1.77× | 426 | 402 | 0.5% | 623 |
| FY 2021 Q4 | Dec 31, 2021 | — | 6,848 | — | — | — | — | — | — | 1.76× | 431 | 405.97 | 2.55% | 857 |
| FY 2021 Q3 | Sep 30, 2021 | — | 5,550 | — | — | — | — | — | — | 1.35× | 434 | 404 | 2.28% | 0 |
| FY 2021 Q2 | Jun 30, 2021 | — | 5,603 | — | — | — | — | — | — | 1.24× | 431 | 402 | 5.51% | 0 |
| FY 2021 Q1 | Mar 31, 2021 | — | 5,442 | — | — | — | — | — | — | 1.39× | 430 | 400 | 13.31% | 0 |
| FY 2020 Q4 | Dec 31, 2020 | — | 2,623.85 | — | — | — | — | — | — | 1.43× | 395.89 | 395.89 | — | — |
| FY 2020 Q3 | Sep 30, 2020 | — | 1,505.58 | — | — | — | — | — | — | 2.43× | 395 | 395 | — | — |
| FY 2020 Q2 | Jun 30, 2020 | — | 1,761.63 | — | — | — | — | — | — | 17.3× | 381 | 381 | — | — |
| FY 2020 Q1 | Mar 31, 2020 | — | 391.72 | — | — | — | — | — | — | 9.29× | 353 | 353 | — | — |
| FY 2019 Q4 | Dec 31, 2019 | — | 235.88 | — | — | — | — | — | — | 7.89× | — | — | — | — |
| FY 2019 Q3 | Sep 30, 2019 | — | 173.71 | — | — | — | — | — | — | 7.4× | — | — | — | — |
| FY 2019 Q2 | Jun 30, 2019 | — | 151.62 | — | — | — | — | — | — | 6.77× | — | — | — | — |
| FY 2019 Q1 | Mar 31, 2019 | — | 502.93 | — | — | — | — | — | — | 7.17× | — | — | — | — |
Sources and calculations
Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.
Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.
The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.
Debt uses reported borrowings, with overlapping concepts treated as alternatives. Cash excludes restricted cash and short-term investments. Dilution compares split-normalized weighted average basic shares year over year. Share buyback spending does not by itself measure shares retired.
Market prices: Yahoo Finance · MRNA, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.
- Total debt
- Reported borrowing balances. Uses an aggregate including current maturities, or current plus noncurrent debt. Adds separately disclosed short-term borrowings, with commercial paper as a fallback, unless the selected current/aggregate concept already includes them. Finance leases are included when part of the reported debt concept; undisclosed components are not estimated.
- Cash & equivalents
- Unrestricted reported cash and cash equivalents. Excludes short-term investments and restricted cash.
- Net debt
- Total debt − cash and equivalents. Negative means net cash.
- Debt / equity
- Total debt / equity including noncontrolling interests. Nonpositive equity yields unavailable.
- Debt / assets
- Total debt / total assets × 100.
- Net debt / EBITDA
- Period-end net debt / (TTM operating income + TTM depreciation and amortization). Negative net debt is retained.
- Debt / FCF
- Period-end reported debt / positive TTM free cash flow. Reflects the selected reported capex scope and SBC option.
- Interest coverage
- TTM operating income / positive TTM interest expense. IFRS finance costs can include more than interest.
- Current ratio
- Current assets / positive current liabilities.
- Diluted shares
- Reported weighted average diluted shares, normalized for subsequent recorded stock splits. Fourth-quarter counts use a day-weighted annual/nine-month reconstruction where possible.
- Basic shares
- Reported weighted average basic shares, normalized for subsequent recorded stock splits.
- Share count growth
- Year-over-year change in split-normalized weighted average basic shares × 100. A dilution proxy; negative means a lower share count.
- Share repurchases
- Reported cash payments for repurchase of common shares. This is spending, not a buyback yield.